SecBot SecBot
SECBOTREPLAY Home › Report › LXRX

LXRX · Lexicon Pharmaceuticals, Inc

LEXICON PHARMACEUTICALS, INC. · DEFA14A filed Mar 16, 2026 at 16:04 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Mar 16, 2026 at 16:04 ET

Lexicon Pharmaceuticals, Inc. has filed a definitive additional materials proxy statement (DEFA14A) related to a shareholder vote. The filing appears to be routine and does not contain material financial information or indicate an activist campaign.

  • Filing is a DEFA14A, which is a definitive additional materials proxy statement.
  • The filing is routine and does not contain material financial data.
  • No activist campaign or significant corporate action is indicated in the available documents.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access